Non Hodgkin Lymphoma News and Research

RSS
Drug used in stem cell therapy may protect against smoke-induced lung injury

Drug used in stem cell therapy may protect against smoke-induced lung injury

Some tumors use two levels of protection against immune system, shows study

Some tumors use two levels of protection against immune system, shows study

Study finds increase in lifestyle-related cancers over the past decade

Study finds increase in lifestyle-related cancers over the past decade

New 'lymphoma micro-reactor' device targets chemo-resistant tumors

New 'lymphoma micro-reactor' device targets chemo-resistant tumors

New insights into breast implant-associated anaplastic large-cell lymphoma

New insights into breast implant-associated anaplastic large-cell lymphoma

Researchers propose alternative treatment to target lymphoma signaling at its root

Researchers propose alternative treatment to target lymphoma signaling at its root

Gene-editing technology enhances T cell immunotherapies for treating cancer

Gene-editing technology enhances T cell immunotherapies for treating cancer

Study reveals HCT as effective treatment for NHL patients regardless of age

Study reveals HCT as effective treatment for NHL patients regardless of age

Caris Life Sciences reveals identification of new mechanism of action to treat NHL

Caris Life Sciences reveals identification of new mechanism of action to treat NHL

Researchers question exclusion of people with prior cancer history from clinical trials

Researchers question exclusion of people with prior cancer history from clinical trials

California cracks down on weed killer as lawsuits abound

California cracks down on weed killer as lawsuits abound

New category of immunotherapy appears safe to use in patients with both cancer and HIV

New category of immunotherapy appears safe to use in patients with both cancer and HIV

FDA grants accelerated approval to new treatment for mantle cell lymphoma

FDA grants accelerated approval to new treatment for mantle cell lymphoma

VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients

VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

New CAR-T cell therapy offers effective option for certain blood cancer patients

New CAR-T cell therapy offers effective option for certain blood cancer patients

Novel gene expression signature assay could help enhance lymphoma management

Novel gene expression signature assay could help enhance lymphoma management

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

Female cancer survivors have higher risks of poor pregnancy outcomes, study finds

Female cancer survivors have higher risks of poor pregnancy outcomes, study finds